
Venture capital formation has seen a significant decline in 2024, according to an analysis by Stifel. Multiple factors, including the Inflation Reduction Act (IRA), a weaker market, and a slow pace of private equity exits, are impacting the flow of fresh capital into venture funds. The venture capital landscape is experiencing a 'traffic jam,' with many Series A companies struggling to raise Series B rounds. Only 10% of companies that raised their Series A in the first half of 2022 have progressed to Series B, a much lower rate than in previous years. Companies with strong growth prospects, such as those with $4 million in ARR and 100%+ growth, should still be able to secure significant funding, such as $10 million on $50 million+. Bridge financing activity has also declined after reaching record highs in 2023, possibly signaling a shift in investor focus back to new primary investments. Enterprise SaaS, traditionally a strong sector for venture capital with high exit success rates, saw a decrease in deal volume in 2023, marking the lowest level since 2017.
Enterprise SaaS, historically a mainstay for VCs with the best expected exit success rates, saw sentiment wane in 2023 with the lowest deal volume since 2017. The question of when the exit market will heat back up remains unanswered. https://t.co/zru1OWigh9
Epoch 25: Biotech 2024 - Beg vs. Bridge 👉 Valuations vs deal volume - mixed valuation trends & less deals 👉 Valuation vs round size - higher valuation & bigger deal size 👉 To bridge or not to bridge - leading indicators for Q2 deal volume (L!nk… https://t.co/WU4FfoozeX
No more (VC) bridges to nowhere? Bridge activity declining in recent months after being at record highs in 2023. Perhaps a signal more investors are going to turn attention back to new primary investments soon? (bridges here refer to priced rounds from VCs already on the cap) https://t.co/Xd5QJZHuyc
